Statistical methods in cardiovascular trials
The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.
Hazard ratio
ANCOVA
Cox proportional-hazards model
Non-inferiority trial design
Multiple imputation / missing data
Odds ratio
Log-rank test
t-test
All cardiovascular trials
965 results
- VISSITIndependent statistical analysis and educational interpretation of VISSIT (NCT00816166), a randomized phase 2/3 trial of the Pharos Vitesse Neurovascular Stent System plus medical therapy versus medical therapy for ischemic stroke and transient…
- VITALITY-HFpEFIndependent statistical analysis of Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03547583).
- VOYAGER PADA detailed independent statistical analysis of VOYAGER PAD, the randomized phase 3 trial of rivaroxaban plus aspirin versus placebo plus aspirin in symptomatic peripheral artery disease undergoing lower-extremity peripheral revascularization.
- VRIndependent statistical analysis of Immersive Virtual Reality in Stroke Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04429945).
- WAKE-UPIndependent statistical analysis of the WAKE-UP phase 3 trial evaluating MRI-based thrombolysis with alteplase in wake-up stroke, including design, endpoints, planned statistical methods, and interpretation.
- WARCEFComplete statistical analysis of the WARCEF trial, comparing warfarin with aspirin in patients with reduced cardiac ejection fraction, including trial design, time-to-event endpoints, Cox and Poisson regression, reported results, safety, and statistical…
- WASIDIndependent statistical analysis of WASID, a randomized, double-blind phase 3 trial comparing aspirin and warfarin for stroke prevention. The page explains the trial design, available registry information, planned statistical interpretation, and important…
- WEARIT-FRIndependent statistical analysis of LifeVest Safety and Efficacy in Real Life Settings in France: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03319160).
- WISDOMAn independent statistical analysis of the WISDOM trial evaluating withdrawal versus continuation of amiodarone in successfully treated patients with persistent atrial fibrillation.
- WOESTIndependent statistical analysis of WOEST (NCT00769938), a randomized phase 4 trial evaluating antiplatelet and anticoagulant therapy strategies in patients undergoing coronary stenting with oral anticoagulation.
- WU197Independent statistical analysis of Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00656851).
- YELLOW IIIIndependent statistical analysis of Effect of Evolocumab on Coronary Plaque Characteristics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04710368).
- ZENITHIndependent statistical analysis of A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH): primary endpoint results, effect estimate with confidence interval,…
- ZEUSIndependent statistical analysis of the ZEUS phase 3 trial evaluating zotarolimus-eluting stent versus bare metal stent implantation in patients with coronary artery disease.
- ZODIACIndependent statistical analysis of OptimiZation Of Lipid Lowering Therapies Using a Decision Support System In Patients With Acute Coronary Syndrome.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…